Literature DB >> 1869305

Interaction of CD4 with HLA class II antigens and HIV gp120.

D Piatier-Tonneau1, L N Gastinel, F Amblard, M Wojcik, P Vaigot, C Auffray.   

Abstract

We have developed a cellular adhesion assay in which B lymphocytes expressing HLA class II antigens form rosettes with COS cells expressing high levels of cell surface CD4 upon transient transfection with a CDM8-CD4 plasmid construct. The assay is specific, quantitative, and overcomes the difficulties encountered with a previously described system using an SV40 viral vector. Rosette formation was inhibited by a series of CD4- and HLA-DR-specific antibodies, as well as by human immunodeficiency virus (HIV) gp 120, and a synthetic peptide derived from part of its binding site for CD4 (amino acid residues 414-434), but not by a variety of other effectors, including several soluble CD4 derivatives. The comparison of this pattern of inhibition with those observed in other systems further emphasizes the great similarity, but incomplete identity, in the CD4 binding sites for HLA class II antigens and HIV gp120, and supports a model in which CD4 is considered as an allosteric servomodulator of T-cell adhesion and function which probably is induced to interact with HLA class II antigens when associated with the Tcr/CD3 complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869305     DOI: 10.1007/bf00211424

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  37 in total

1.  Interaction between CD4 and class II MHC molecules mediates cell adhesion.

Authors:  C Doyle; J L Strominger
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

2.  Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.

Authors:  A Traunecker; J Schneider; H Kiefer; K Karjalainen
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.

Authors:  L K Clayton; M Sieh; D A Pious; E L Reinherz
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

4.  The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family.

Authors:  P J Maddon; D R Littman; M Godfrey; D E Maddon; L Chess; R Axel
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

5.  Immunosuppressive properties of synthetic peptides derived from CD4 and HLA-DR antigens.

Authors:  F Mazerolles; A Durandy; D Piatier-Tonneau; D Charron; L Montagnier; C Auffray; A Fischer
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

6.  Cell-cell adhesion mediated by CD8 and MHC class I molecules.

Authors:  A M Norment; R D Salter; P Parham; V H Engelhard; D R Littman
Journal:  Nature       Date:  1988-11-03       Impact factor: 49.962

Review 7.  The CD4 antigen: physiological ligand and HIV receptor.

Authors:  Q J Sattentau; R A Weiss
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

8.  Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.

Authors:  A Ashkenazi; L G Presta; S A Marsters; T R Camerato; K A Rosenthal; B M Fendly; D J Capon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

9.  HIV-infected cells are killed by rCD4-ricin A chain.

Authors:  M A Till; V Ghetie; T Gregory; E J Patzer; J P Porter; J W Uhr; D J Capon; E S Vitetta
Journal:  Science       Date:  1988-11-25       Impact factor: 47.728

Review 10.  CD4-targeted immune intervention: a strategy for the therapy of AIDS and autoimmune disease.

Authors:  C Auffray; D Piatier-Tonneau; G Kroemer
Journal:  Trends Biotechnol       Date:  1991-04       Impact factor: 19.536

View more
  2 in total

1.  Genetic variability of the human CD4 V2 domain.

Authors:  S Indraccolo; M Mion; R Biagiotti; S Romagnani; M Morfini; G Longo; R Zamarchi; L Chieco-Bianchi; A Amadori
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

2.  Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.

Authors:  E Baixeras; B Huard; C Miossec; S Jitsukawa; M Martin; T Hercend; C Auffray; F Triebel; D Piatier-Tonneau
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.